WUXI BIOLOGICS CAYMAN ADR - WXXWY
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | History | No change | 9,788 | 86 | 0.0% | 0.0% | 1 | 0 | 0.0% | Q2 2026 | Aug 11, 2026 |
| PNC FINANCIAL SERVICES GROUP, INC. | History | No change | 5,383 | 47 | 0.0% | 0.0% | 2 | 0 | 0.0% | Q2 2026 | Aug 07, 2026 |
| GAMMA Investing LLC | History | Added to | 2,531 | 36 | 0.0% | 0.0% | 3 | +612 | 31.89% | Q3 2026 | Oct 08, 2026 |
| Westside Investment Management, Inc. | History | No change | 2,229 | 19 | 0.0% | 0.0% | 4 | 0 | 0.0% | Q2 2026 | Jul 27, 2026 |
| IMA Advisory Services, Inc. | History | No change | 44 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 10, 2026 |